GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Myungmoon Pharm Co 017180.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

1,099

-0.45%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩195.25bn

FY2016FY2025

Net income

₩1.90bn

FY2016FY2025

Free cash flow

−₩8.54bn

FY2016FY2025

Shareholders' equity

₩98.74bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩195.25bn₩186.44bn₩169.57bn₩152.13bn₩144.76bn₩127.85bn₩149.35bn₩147.50bn₩140.14bn₩142.18bn
Gross profit₩106.92bn₩104.97bn₩95.35bn₩78.10bn₩62.34bn₩48.99bn₩68.43bn₩74.45bn₩79.20bn₩76.18bn
Research and development₩3.99bn₩2.06bn₩2.97bn₩1.71bn₩2.06bn₩535.1m₩676.5m₩140.6m₩140.6m₩140.6m
Operating income₩6.83bn₩1.93bn₩963.8m₩6.43bn−₩5.88bn−₩28.96bn−₩14.75bn₩4.94bn₩7.47bn₩10.06bn
Net income₩1.90bn−₩3.03bn−₩4.52bn₩7.87bn−₩6.86bn−₩27.64bn−₩20.40bn₩988.3m₩7.81bn₩6.75bn
Diluted earnings per share77.70-124.40-185.50322.56-281.42-1,133.09-836.4140.52320.00276.41

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩272.46bn₩257.99bn₩236.55bn₩230.45bn₩222.68bn₩243.03bn₩264.44bn₩243.07bn₩235.08bn₩221.08bn
Total liabilities₩168.00bn₩154.87bn₩147.79bn₩135.18bn₩136.80bn₩152.25bn₩184.25bn₩150.00bn₩133.36bn₩126.40bn
Debt₩42.65bn₩35.25bn₩12.58bn₩6.09bn₩4.96bn₩6.39bn₩116.03bn₩100.79bn₩87.20bn₩83.68bn
Shareholders' equity₩98.74bn₩96.85bn₩83.45bn₩89.52bn₩80.26bn₩87.20bn₩76.51bn₩89.68bn₩97.71bn₩90.99bn
Shares outstanding24m24m24m24m24m24m24m24m24m24m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩1.70bn−₩1.34bn−₩5.18bn₩5.47bn₩855.0m−₩16.67bn−₩2.94bn₩11.41bn₩8.02bn₩5.60bn
Capital spending−₩6.83bn−₩1.40bn−₩2.99bn−₩1.95bn−₩374.7m−₩2.01bn−₩11.97bn−₩10.93bn−₩18.87bn−₩9.46bn
Free cash flow−₩8.54bn−₩2.74bn−₩8.17bn₩3.53bn₩480.3m−₩18.68bn−₩14.91bn₩478.5m−₩10.84bn−₩3.86bn
Dividends paid———————−₩2.39bn−₩1.15bn−₩323.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩51.21bn₩48.00bn₩50.75bn₩49.86bn₩48.76bn₩45.87bn₩49.15bn₩46.98bn
Gross profit₩29.64bn₩26.84bn₩28.37bn₩26.72bn₩27.77bn₩24.06bn₩27.62bn₩26.34bn
Operating income−₩836.4m₩293.5m₩1.76bn₩453.8m₩5.68bn−₩911.6m₩1.60bn₩902.1m
Net income−₩1.26bn−₩801.8m₩943.2m−₩549.0m₩3.43bn−₩1.93bn₩508.1m−₩794.2m
Diluted earnings per share-51.69-32.8738.67-22.51140.74-79.2020.83-32.56
Cash from operations−₩3.03bn−₩374.0m₩519.0m−₩664.0m−₩765.0m−₩793.0m₩3.62bn−₩2.88bn
Capital spending−₩1.16bn−₩1.02bn−₩3.05bn−₩1.21bn−₩101.0m−₩2.46bn−₩441.0m−₩415.0m
Free cash flow−₩4.19bn−₩1.40bn−₩2.53bn−₩1.88bn−₩866.0m−₩3.25bn₩3.18bn−₩3.30bn
Total assets₩300.16bn₩273.93bn₩272.46bn₩270.19bn₩270.73bn₩258.91bn₩257.99bn₩232.50bn
Debt₩21.18bn₩42.45bn₩42.65bn₩41.09bn₩41.29bn₩36.78bn₩35.25bn₩35.12bn
Shareholders' equity₩97.59bn₩97.92bn₩98.74bn₩97.76bn₩98.32bn₩94.91bn₩96.85bn₩79.66bn

Financial ratios

Data as of 15 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin54.8%56.3%56.2%51.3%43.1%38.3%————
Operating margin3.5%1.0%0.6%4.2%-4.1%-22.7%————
Net margin1.0%-1.6%-2.7%5.2%-4.7%-21.6%————
Return on equity1.9%-3.1%-5.4%8.8%-8.6%-31.7%————
Return on assets0.7%-1.2%-1.9%3.4%-3.1%-11.4%————
Free cash flow yield——————28.3%70.0%84.3%47.2%
Revenue growth4.7%10.0%11.5%5.1%13.2%-14.4%————
Earnings growth-162.5%-32.9%-157.5%-214.6%-75.2%35.5%————
Current ratio0.96x0.87x0.70x0.64x0.60x0.64x————
Debt to equity0.43x0.36x0.15x0.07x0.06x0.07x————
Equity ratio36.2%37.5%35.3%38.8%36.0%35.9%————
Interest coverage1.34x0.36x0.19x1.72x-1.93x-6.99x————
R&D as a share of sales2.0%1.1%1.8%1.1%1.4%0.4%————
Buybacks as a share of market value——————0.0%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.7%8.8%4.6%
Operating income2.0%——
Net income-37.8%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.5%54.8%50.9%50.8%
Operating margin2.3%2.3%-1.9%-0.8%
Net margin-0.3%0.3%-3.3%-3.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings23.8-14.6-12.38.9-16.8-6.4-5.7124.217.718.4
Price to sales0.20.20.30.50.81.40.80.81.00.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Dec 2017.

FY2018FY2017FY2016FY2014FY2011FY2010FY2009
Paid in the year97.94347.29217.01729.62824.68256.51633.292
  • 1.021-for-1 split · 3 Jan 2018
  • 1.036-for-1 split · 28 Dec 2016
  • 1.034-for-1 split · 29 Dec 2015
  • 1.035-for-1 split · 29 Dec 2014
  • 1.03-for-1 split · 27 Dec 2013
  • 1.042-for-1 split · 28 Dec 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.